You can now use Deep Research without $200 — from flexos.work
Accelerating scientific breakthroughs with an AI co-scientist — from research.google by Juraj Gottweis and Vivek Natarajan
We introduce AI co-scientist, a multi-agent AI system built with Gemini 2.0 as a virtual scientific collaborator to help scientists generate novel hypotheses and research proposals, and to accelerate the clock speed of scientific and biomedical discoveries.
Now decides next: Generating a new future — from Deloitte.com
Deloitte’s State of Generative AI in the Enterprise Quarter four report
There is a speed limit. GenAI technology continues to advance at incredible speed. However, most organizations are moving at the speed of organizations, not at the speed of technology. No matter how quickly the technology advances—or how hard the companies producing GenAI technology push—organizational change in an enterprise can only happen so fast.
Barriers are evolving. Significant barriers to scaling and value creation are still widespread across key areas. And, over the past year regulatory uncertainty and risk management have risen in organizations’ lists of concerns to address. Also, levels of trust in GenAI are still moderate for the majority of organizations. Even so, with increased customization and accuracy of models—combined with a focus on better governance— adoption of GenAI is becoming more established.
Some uses are outpacing others. Application of GenAI is further along in some business areas than in others in terms of integration, return on investment (ROI) and expectations. The IT function is most mature; cybersecurity, operations, marketing and customer service are also showing strong adoption and results. Organizations reporting higher ROI for their most scaled initiatives are broadly further along in their GenAI journeys.